Antibodies against IL-7R alpha subunit and uses thereof

Provided herein are antibodies that bind to the alpha subunit of an IL-7 receptor (IL-7Rα). Also provided are uses of these antibodies in therapeutic applications, such as treatment of inflammatory diseases. Further provided are cells that produce the antibodies, polynucleotides encoding the heavy and/or light chain regions of the antibodies, and vectors comprising the polynucleotides..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 05. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

YAMNIUK AARON PAUL [VerfasserIn]
BRODEUR SCOTT RONALD [VerfasserIn]
DEYANOVA EKATERINA [VerfasserIn]
HUANG RICHARD YU-CHENG [VerfasserIn]
WANG YUN [VerfasserIn]
LANGISH ALFRED ROBERT [VerfasserIn]
CHEN GUODONG [VerfasserIn]
CARL STEPHEN MICHAEL [VerfasserIn]
SHEN HONG [VerfasserIn]
PASHINE ACHAL MUKUNDRAO [VerfasserIn]
SU LIN HUI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-05, Last update posted on www.tib.eu: 2024-03-27, Last updated: 2024-03-29

Patentnummer:

US11919962

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA001072587